A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

A new spatial genomic scoring system outdoes existing tools at identifying patients at risk of recurring liver tumours.

A new study reveals that the genetic defect behind spinal muscular atrophy may also cause long-term liver issues for both patients and carriers.

A new spatial multi-omics tool merges different levels of biological data from the same tissue sample to better differentiate finer details at different health states.

Hormone traces in aquaculture tank water offer a less intrusive way to monitor the health of popular Asian fish farm stocks.

Cell and gene therapies are driving the next revolution in medicine, combining the best of biology with game-changing technologies from A*STAR researchers and partners.

Researchers uncovered how specialised stem cells act as building blocks for the esophagus, shaping its development and offering insights into treating related diseases.

A comprehensive study of liver tumours reveals that a small fraction of aggressive cells can have an outsized effect on patient outcomes.

High iron levels, often linked to red meat consumption, can fuel cancer growth by reactivating proteins that allow cancer cells to divide endlessly.

A new wearable sensor continuously detects key chemical biomarkers directly from the skin, circumventing more invasive clinical methods.

A new sensor innovation measures stress inside tissue models to simulate disease conditions like cancer with greater accuracy.

A deeper look at nanoparticle design reveals how customised lipid carriers with advanced structures can greatly enhance the delivery of mRNA treatments.

In recognition of their scientific contributions and impact both locally and globally, 14 leading researchers have been awarded the 2024 A*STAR Fellowship.